PDE6 Delta Inhibitors for Epilepsy and Neurodegenerative Disorders, Remynd N.V., EP3634407A1
Summary
The EPO published patent application EP3634407A1 disclosing PDE6 Delta inhibitors for the prevention and/or treatment of epilepsy and/or neurodegenerative disorders. The applicant is Remynd N.V. (inventors: Griffioen, Princen, Van Dooren, De Witte). The application has been classified under IPC A61K 31/422 and designated across 31 European states including DE, FR, GB, IT, NL, ES, PL, SE, and others. This A1 publication includes the search report and covers pharmaceutical compositions comprising PDE6 Delta inhibitors as active agents.
“INHIBITORS OF PDE6DELTA FOR USE IN THE PREVENTION AND/OR TREATMENT OF EPILEPSY AND/OR NEURODEGENERATIVE DISORDERS”
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 72 changes logged to date.
What changed
The EPO published patent application EP3634407A1 disclosing pharmaceutical compositions comprising PDE6 Delta inhibitors for use in preventing or treating epilepsy and/or neurodegenerative disorders. The application claims priority to IPC classifications A61K 31/422, A61K 45/00, A61P 25/08, and A61P 25/28.
For pharmaceutical companies and biotechnology firms engaged in CNS drug development, this patent publication signals competitive activity in the PDE6 Delta inhibitor space for neurological indications. R&D teams pursuing similar therapeutic approaches should review the claims for freedom-to-operate considerations and assess potential licensing opportunities with Remynd N.V.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
INHIBITORS OF PDE6DELTA FOR USE IN THE PREVENTION AND/OR TREATMENT OF EPILEPSY AND/OR NEURODEGENERATIVE DISORDERS
Publication EP3634407A1 Kind: A1 Apr 15, 2026
Applicants
Remynd N.V.
Inventors
GRIFFIOEN, Johan, Gerard, PRINCEN, Katrien, VAN DOOREN, Tom, François, L., DE WITTE, Koen
IPC Classifications
A61K 31/422 20060101AFI20181116BHEP A61K 45/00 20060101ALI20181116BHEP A61P 25/08 20060101ALI20181116BHEP A61P 25/28 20060101ALI20181116BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.